Integrated Safety Update of Abrocitinib in 3802 Patients With Moderate-to-Severe Atopic Dermatitis: Data From More Than 5200 Patient-Years With Up to 4 Years of Exposure

media

posted on 2024-06-16, 23:36 authored by Adis Journals on behalf of:, Eric L. Simpson, Jonathan I. Silverberg, Audrey Nosbaum, Kevin Winthrop, Emma Guttman-Yassky, Karin M. Hoffmeister, Alexander Egeberg, Hernan Valdez, Haiyun Fan, Saleem A. Farooqui, Gary Chan, Justine Alderfer, William Romero, Kanti Chittuluru

Article full text

The above features represent the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).